TOKYO (Reuters) – Pfizer Inc said on Friday it applied for Japanese government approval for its oral COVID-19 treatment.
Japanese Prime Minister Fumio Kishida said last month he spoke with Pfizer CEO Albert Bourla to secure 2 million doses of Pfizer’s antiviral pill.
(Reporting by Rocky Swift; Editing by Jacqueline Wong)
